Logo Made in Germany BIO 2017

Anavex Life Sciences Expands with Promising Alzheimer Treatment to Bavaria

The New York-based Anavex Life Sciences Corp. (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system diseases, pain and various types of cancer expanded to Martinsried (Munich, Bavaria) in December 2016.

Exhibitor: Bavarian U.S. Offices for Economic Development, LLC East Coast Division

Your personal organizer

Your personal organizer

Print list  |  Save as PDF
Xell AG
Booth number: